-
Esperion Therapetuics Surges 13%
Wednesday, March 2, 2016 - 12:45pm | 218Read More...Shares of Esperion Therapeutics Inc (NASDAQ: ESPR) surged higher by more than 13 percent on Wednesday after the company's director, Gilbert Omenn, disclosed an insider purchase of 5,000 shares of company stock. Omenn disclosed in a regulatory filing he bought 5,000 shares of Esperion's stock on...
-
Biotech Investors Shouldn't Fear Legislation, Even If Hillary Is President And Dems Win Senate Majority
Wednesday, February 24, 2016 - 12:00pm | 382Read More...In a new report, Evercore ISI analyst Terry Haines discussed the potential for some form of drug pricing legislation in the U.S. within the next two years. The SPDR S&P Biotech (ETF) (NYSE: XBI) is down 35.3 percent in the past six months since Democratic presidential front-runner Hillary...
